Menu
Back to Journals » Cancer Management and Research » Volume 12
Original Research
FOLFOX vs FOLFIRI as Second-line of Therapy After Progression to Gemcitabine/Nab-paclitaxel in Patients with Metastatic Pancreatic Cancer
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 11,827 | Dovepress* | 10,435+ | 788 | 11,223 | |
| PubMed Central* | 1,392 | 178 | 1,570 | ||
| Totals | 11,827 | 966 | 12,793 | ||
| *Since 19 October 2020 | |||||
View citations on PubMed Central and Google Scholar